Advertisement

Topics

AmorChem Company Profile

03:46 EST 11th December 2018 | BioPortfolio

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating primarily from Canadian universities and research centres. Launched in 2011, the AmorChem fund model combines access to financial resources with a virtual incubator structure that enables the rapid development and commercialization of its technologies. The first fund (41.2M$) has built a portfolio of 24 technologies and successfully transacted three pharma exits as well as spun-out seven companies. The attractiveness of this seed fund model and the role it plays in the investment ecosystem were highlighted in September 2017 with the launch of the AmorChem II Fund, which now totals $53.7M.


News Articles [5 Associated News Articles listed on BioPortfolio]

Amorchem Selected for Investment by the Venture Capital Catalyst Initiative

November 6th, 2018, AmorChem is proud to be amongst the successful applicants of the Venture Capital Catalyst Initiative (“VCCI”) Stream II, announced yesterday in Montreal by...

Inversago brings in $7mm via Series A

Inversago Pharma Inc. raised $7mm through its Series A financing co-led by Genesys Capital and AmorChem, which were joined by JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Tarnagulla Ventures, and a...

SemaThera Board Names Garth Cumberlidge as President & CEO

SemaThera Inc., announces today that its board of directors has appointed Garth Cumberlidge as President and Chief Executive Officer. Dr. Cumberlidge was also elected to the board...

Mperia Therapeutics Appoints Paul Chipperton as President and CEO

November 9, 2018, Mperia’s Board of Directors announces today the appointment of Mr Paul Chipperton, as the new President and CEO, effective immediately. He will lead CD36 devel...

Inversago Pharma Receives $7 Million in Series A Financing

Proceeds will support the development of new generations of cannabinoid-1 (CB1) receptor inverse agonists for the treatment of several metabolic diseases including Prader-Willi Sy...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

AmorChem

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...

AMORCHEM L.P.

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...

More Information about "AmorChem" on BioPortfolio

We have published hundreds of AmorChem news stories on BioPortfolio along with dozens of AmorChem Clinical Trials and PubMed Articles about AmorChem for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AmorChem Companies in our database. You can also find out about relevant AmorChem Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record